PharmaDrug Grants Stock Options

This article was originally published on this site

Toronto, Ontario–(Newsfile Corp. – February 5, 2021) – PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company”) announces the grant of stock options to directors, officers and consultants to purchase 5,200,000 common shares of the Company, exercisable at $0.085 per share at any time on or before February 4, 2026. The grants are subject to the terms of the Company’s stock option plan. In accordance with regulatory requirements, any shares issued pursuant…
Read more on “Newsfile”